 Colonic ischemia immunotherapy interferon-alpha Colonic ischemia CI rare complication high-dose immunotherapy complication patients metastatic cancer high-dose therapy CI patients interferon-alpha IFN none patients Severe diarrhea equal bowel movements/day common patients IFN clinical diagnosis CI patients patients severe diarrhea CI Hematochezia patients IFN CI patient nonspecific colitis Differences vasopressor use risk CI patients IFN IFN phenylephrine patients administration lymphokine-activated killer LAK cells significant effect incidence CI severe diarrhea peritonitis vasopressor use patients CI ischemic episode hours last LAK cell infusions conclusion CI unusual complication high-dose IFN immunotherapy patients combination therapy severe diarrhea risk factor subsequent occurrence CI